Research Article


DOI :10.26650/IUITFD.2020.0101   IUP :10.26650/IUITFD.2020.0101    Full Text (PDF)

EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES

Muhammed Emin DemirkolMusa KayaSüleyman ÖzsarıEmine Özsarı

Objective: COVID-19 infection caused by the SARS-CoV-2 which was initially detected in China during the last days of 2019 has spread to the whole world in a short period of time causing a pandemic with devastating results. In performing this study, we aimed to reveal the differences in laboratory findings of COVID-19 cases accompanied by chronic diseases compared to the cases without any pre-existing medical condition. Methods: This is a retrospective cross-sectional study and consists of 226 patients diagnosed with COVID-19 who applied to health institutions in Bolu, Turkey between 11.03.2020 and 26.05.2020. Results: The mean age of the patients included in the study was 61.95±16.82 (min: 32-max: 93), 126 (55.8%) of the patients were women and 100 (44.2%) were men. Seventy-five (33.2%) had at least one chronic disease. The most prevalent comorbid diseases in our patients were found to be hypertension (15.9%), chronic obstructive pulmonary disease (14.6%) and diabetes mellitus (9.7%). Findings such as leukocytosis, basophilia and neutrophilia, elevated CRP, elevated D-DIMER and elevated LDH, which are relatively common in COVID-19 cases, were more extensive in cases accompanied by underlying diseases. Conclusion: Impaired laboratory findings of COVID-19 patients with concomitant chronic diseases are more severe than the group without additional disease. We recommend that there can be more studies in which all parameters that may affect the results are evaluated.

DOI :10.26650/IUITFD.2020.0101   IUP :10.26650/IUITFD.2020.0101    Full Text (PDF)

KRONİK HASTALIĞI OLAN COVİD-19 VAKALARININ LABORATUVAR PARAMETRELERİNİN DEĞERLENDİRİLMESİ

Muhammed Emin DemirkolMusa KayaSüleyman ÖzsarıEmine Özsarı

Amaç: 2019 yılının son günlerinde ilk olarak Çin’de tespit edilen SARS-CoV-2 (Yeni Tip Coronavirüs) virüsünün sebep olduğu COVID-19 enfeksiyonu kısa bir zaman diliminde, bütün dünyaya yayılarak yıkıcı sonuçlara sebep veren pandemiye yol açmıştır. Bu çalışma ile kronik hastalığı olan COVID-19 vakalarının eşlik eden herhangi bir hastalığı olmayan vakalara kıyasla laboratuvar bulgularındaki farklılıkları ortaya koymayı amaçladık. Gereç ve Yöntem: Bu çalışma kesitsel tipte retrospektif özellikte olup 11.03.2020 ve 26.05.2020 tarihleri arasında Bolu’daki sağlık kurumlarına başvurup COVID-19 tanısı almış 226 hastadan oluşmaktadır. Bulgular: Çalışmaya dahil edilen 226 hastanın yaş ortalamasının 61,95±16,82 olduğu (min:32-mak:93); 126’sı (%55,8) kadın, 100’ü (%44,2) erkek hasta olup, 75 (%33,2)’inin kronik hastalığı olduğu saptanmıştır. Hastalarımızda en sık görülen komorbid hastalıkların hipertansiyon (%15,9), kronik obstrüktif akciğer hastalığı (%14,6) ve diabetes mellitus (%9,7) olduğu görüldü. COVID-19 vakalarında sık olarak rastlanan lökositoz, nötrofili ve bazofilinin; ayrıca CRP, LDH ve D-DİMER yüksekliğinin, komorbid hastalığı olan vakalarda olmayanlara göre daha yaygın olduğu saptanmıştır. Sonuç: Eşlik eden kronik hastalıkları olan COVID-19 hastalarına ait bozulmuş laboratuvar bulguları ek hastalığı olmayan gruba göre daha ciddi seyretmektedir. Sonuçları etkileyebilecek tüm parametrelerin değerlendirildiği yeni çalışmalara ihtiyaç vardır. 


PDF View

References

  • 1. Wu Z, Mc Googan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-42. [Epub ahead of print] [CrossRef] google scholar
  • 2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. [CrossRef] google scholar
  • 3. Guan WJ, Ni ZY, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020 [Epub ahead of print] [CrossRef] google scholar
  • 4. Yang R, Gui X, Zhang Y, Xiong Y. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients. Expert Rev Respir Med 2020;1-4. [Epub ahead of print] [CrossRef] google scholar
  • 5. Nandy K, Salunke A, Pathak SK, et al. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Diabetes Metab Syndr 2020;14(5):1017-25. [Epub ahead of print] [CrossRef] google scholar
  • 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et all. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497-506. [CrossRef] google scholar
  • 7. Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180(7):934-43. [Epub ahead of print] [CrossRef] google scholar
  • 8. Zhang J, Wu J, Sun X, et al. Association of hypertension with these verity and fatality of SARS-CoV-2 infection: A meta-analysis. Epidemiol Infect 2020;148:e106. Published online 2020 May 28. [Epub ahead of print] [CrossRef] google scholar
  • 9. Wu ZH, Tang Y, Cheng Q. Diabetes increases the mortality of patients with COVID-19: a meta-analysis .Acta Diabetol. 2020: 1-6. [Epub ahead of print] [CrossRef] google scholar
  • 10. Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoSOne 2020;15(5):e0233147. [CrossRef] google scholar
  • 11. Venkatesulu BP, Chandrasekar VT, Girdhar P, et al. A systematic review and meta-analysis of cancer patients affected by a novel coronavirus. medRxiv. Preprint 2020 May 29. [Epub ahead of print] [CrossRef] google scholar
  • 12. Pranata R, Huang I, Lim MA, Wahjoepramono PEJ, July J. Impact of Cerebrovascular and Cardiovascular Diseases on Mortality and Severity of COVID-19 - Systematic Review, Meta-analysis, and Meta-regression. J Stroke Cerebrovasc Dis 2020;29(8):104949. Published online 2020 May 14. [Epub ahead of print] [CrossRef] google scholar
  • 13. Yang R, Gui X, Zhang Y, Xiong Y. The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients. Expert Rev Respir Med 2020:1-4.Published online 2020 Apr 28. [Epub ahead of print] [CrossRef] google scholar
  • 14. Ferrari D, Motta A, Strollo M, Banfi G, Locatelli M. Routine blood tests as a potential diagnostic tool for COVID-19. Clin Chem Lab Med 2020;58(7):1095-9. [CrossRef] google scholar
  • 15. Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 2020;18(6):1324-9. [CrossRef] google scholar
  • 16. Ambrosino I, Barbagelata E, Ruggieri A, Massiah G ,Giannico O, Politi C, et al. Gender differences in patients with COVID-19: a narrative review. Monaldi Archives for Chest Disease 2020;90:138. [Epub ahead of print] [CrossRef] google scholar
  • 17. Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G. COVID-19 andIndividual Genetic Susceptibility / Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X- Chromosome in Males?. Int J Mol Sci 2020;21(10);3474. [CrossRef] google scholar
  • 18. Gargaglioni LH, Marques DA. Let’s talk about sex in the context of COVID-19. J Appl Physiol 2020;128(6):1533-8. [Epub ahead of print] [CrossRef] google scholar
  • 19. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ 2020;11(1):29. [Epub ahead of print] [CrossRef] google scholar
  • 20. Neha C, Tsering P, Kavita S, Rahul K, Brian B, Qadar P. Sex-derived attributes contributing to SARS-CoV-2 mortality. Am J Physiol Endocrinol Metab 2020;319(3):E562-7. [Epub ahead of print] [CrossRef] google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Demirkol, M.E., Kaya, M., Özsarı, S., & Özsarı, E. (2021). EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES. Journal of Istanbul Faculty of Medicine, 84(2), 158-164. https://doi.org/10.26650/IUITFD.2020.0101


AMA

Demirkol M E, Kaya M, Özsarı S, Özsarı E. EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES. Journal of Istanbul Faculty of Medicine. 2021;84(2):158-164. https://doi.org/10.26650/IUITFD.2020.0101


ABNT

Demirkol, M.E.; Kaya, M.; Özsarı, S.; Özsarı, E. EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES. Journal of Istanbul Faculty of Medicine, [Publisher Location], v. 84, n. 2, p. 158-164, 2021.


Chicago: Author-Date Style

Demirkol, Muhammed Emin, and Musa Kaya and Süleyman Özsarı and Emine Özsarı. 2021. “EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES.” Journal of Istanbul Faculty of Medicine 84, no. 2: 158-164. https://doi.org/10.26650/IUITFD.2020.0101


Chicago: Humanities Style

Demirkol, Muhammed Emin, and Musa Kaya and Süleyman Özsarı and Emine Özsarı. EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES.” Journal of Istanbul Faculty of Medicine 84, no. 2 (May. 2024): 158-164. https://doi.org/10.26650/IUITFD.2020.0101


Harvard: Australian Style

Demirkol, ME & Kaya, M & Özsarı, S & Özsarı, E 2021, 'EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES', Journal of Istanbul Faculty of Medicine, vol. 84, no. 2, pp. 158-164, viewed 17 May. 2024, https://doi.org/10.26650/IUITFD.2020.0101


Harvard: Author-Date Style

Demirkol, M.E. and Kaya, M. and Özsarı, S. and Özsarı, E. (2021) ‘EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES’, Journal of Istanbul Faculty of Medicine, 84(2), pp. 158-164. https://doi.org/10.26650/IUITFD.2020.0101 (17 May. 2024).


MLA

Demirkol, Muhammed Emin, and Musa Kaya and Süleyman Özsarı and Emine Özsarı. EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES.” Journal of Istanbul Faculty of Medicine, vol. 84, no. 2, 2021, pp. 158-164. [Database Container], https://doi.org/10.26650/IUITFD.2020.0101


Vancouver

Demirkol ME, Kaya M, Özsarı S, Özsarı E. EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES. Journal of Istanbul Faculty of Medicine [Internet]. 17 May. 2024 [cited 17 May. 2024];84(2):158-164. Available from: https://doi.org/10.26650/IUITFD.2020.0101 doi: 10.26650/IUITFD.2020.0101


ISNAD

Demirkol, MuhammedEmin - Kaya, Musa - Özsarı, Süleyman - Özsarı, Emine. EVALUATING LABORATORY PARAMETERS OF COVID-19 CASES WITH UNDERLYING CHRONIC DISEASES”. Journal of Istanbul Faculty of Medicine 84/2 (May. 2024): 158-164. https://doi.org/10.26650/IUITFD.2020.0101



TIMELINE


Submitted14.05.2020
Accepted09.09.2020
Published Online15.03.2021

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.